News of Note—Sanofi, ImmusanT and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Dyadic will collaborate with Sanofi to explore how its C1 gene expression platform can be applied to Sanofi's vaccine and biologic offerings. The platform aims to speed development and reduce production costs for biologics. Release

> ImmusanT picked up funding from JDRF to work on a Type 1 diabetes vaccine. FierceBiotech article

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

> A drug combo containing a cancer vaccine showed promise against melanoma in a preclinical study. Release